ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #12,413Hybrid

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Abbreviation (ISO):J. AEROSOL MED. PULM. DRUG DELIVERY
•
Identifier (ISSN):1941-2711(Print)/1941-2703(Online)
•
Publisher:Mary Ann Liebert Inc.
Clarivate IF (2026)
2.2↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Aerosol Medicine and Pulmonary Drug Delivery

WoS Q3
12452.9320182.8720192.6820202.8520213.4420223.42023220241.820252.22026
Annual Impact Factor Metric
Current (2026):2.2
Scopus SJR & RankScopus Q2
0.476
#12,413

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
89

89 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
28articles/year
16.33% Gold OA•65.38% Original Research

Aims & Scope

Journal of Aerosol Medicine and Pulmonary Drug Delivery is the only peer-reviewed journal delivering innovative, authoritative coverage of the health effects of inhaled aerosols and delivery of drugs through the pulmonary system. The Journal is a forum for leading experts, addressing novel topics such as aerosolized chemotherapy, aerosolized vaccines, methods to determine toxicities, and delivery of aerosolized drugs in the intubated patient. Journal of Aerosol Medicine and Pulmonary Drug Delivery coverage includes: Pulmonary drug delivery Airway reactivity and asthma treatment Inhalation of particles and gases in the respiratory tract Toxic effects of inhaled agents Aerosols as tools for studying basic physiologic phenomena.

Topics Covered (Recognized by AI)
MedicineBiologyInternal MedicineChemistryPsychologyAnesthesiologyPsychiatryPhysicsAnatomyOrganic ChemistryImmunologyEngineeringGeographyMeteorologyGeologyMaterials SciencePaleontologyPharmacologySurgeryPhilosophyLinguisticsRadiologyGeneticsThermodynamicsPathologyBiochemistry
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

RESPIRATORY SYSTEM

Q3
Rank65/107
IndexSCIE
JCISCIE2026

RESPIRATORY SYSTEM

Q3
Rank72/107
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.2
Articles / Year27
Total Citations4
2025
IF1.8
Articles / Year43
Total Citations57
2024
IF2
Articles / Year39
Total Citations185
2023
IF3.4
Articles / Year43
Total Citations236
2022
IF3.44
Articles / Year31
Total Citations266

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #12,413Scopus Q2SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.476

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.37

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,980 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations240
3-Year Documents106
Citable Documents98

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate32.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ2
Pharmacology (medical)Q3
Pulmonary and Respiratory MedicineQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区RESPIRATORY SYSTEM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Aerosol Medicine and Pulmonary Drug Delivery (abbr: J. AEROSOL MED. PULM. DRUG DELIVERY, ISSN: 1941-2711) is a peer-reviewed international scholarly journal in the field of Medicine, published by Mary Ann Liebert Inc. in United States since 2008. The periodical holds a Journal Impact Factor (JIF) of 2.20, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.476 (Q2), an H-index of 89.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 28 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,980 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Mary Ann Liebert Inc.
Publication Language
English
Frequency
Quarterly
Founding Year
2008
Indexing & Databases
SCIEScopusPubMed
Editorial Address
MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4ab74300-cca8-4313-856f-bbe9f13a6951
Database Updated: 2026-09-28